2008
$500 Award:
Leal Herlitz, Columbia University Medical Center, New York, NY, USA
Acquisition of Invasion in Lung Adenocarcinoma: Using Laser Capture
Microdissection and Comparative Genomic Hybridization To Analyze Segmental
Copy Number Changes of Chromosome 7
$100 Awards:
Catherine Chung, University Health Network, University of Toronto,
Toronto, Canada
p16/CDKN2A Deletion as a Diagnostic Marker To Distinguish Benign from
Malignant Mesothelial Proliferations
Jonathon Herbst, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Evidence-Based Criteria To Distinguish Metastatic Breast Cancer from Primary
Lung Neoplasms on Frozen Section
Matthias Hofer, Brigham and Women's Hospital, Boston MA, USA
The Extent of Sarcomatoid Component Is an Independent Predictor of Survival
in Malignant Mesothelioma
Ruta Gupta, Cedars Sinai Medical Center, Los Angeles, CA, USA
Lessons Learnt from Mistakes and Deferrals in Frozen Section Diagnosis of
Pulmonary Lesions: An Evidence Based Pathology Approach
2005: Hannelore Kothmaier, MS, Institute of Pathology, Graz, Austria
Gene Silencing of PCNA in Mesothelioma Cell Lines Causes Deregulation of
Other Genes
2004: Deepak Mohan, MD, University of Pittsburgh Medical Center
Molecular Analysis of Mesothelial Cell Hyperplasia Assists Diagnosis
2003: Dr. Diana Ionescu, M.D. University of Pittsburgh Medical Center
Amplification in the Thymic Epithelial Tumors
2001: Eizaburo Sasatomi,
MD, Department of Pathology University of Pittsburgh Medical Center,
Pittsburgh, PA
The Majority of Lymphnode Metastasis in Non-Small Cell Lung Cancer (NSCLC)
Arise Early in Primary Lung Tumor Development
2000: Gordana Verstovsek, M.D., of
Baylor College of Medicine, Houston, Texas
Vitamin D Receptor Expression in
Emphysema: Potential for Role in Tissue Remodeling
1998: Nader T. Okby, MD, Armed
Forces Institute of Pathology and National Cancer Institute
p27 immunohistochemical expression in non-small cell lung carcinomas (NSCLC)
1997: Valerie Holst, MD, University of Pittsburgh
p53 and Kras mutational Genotyping in Pulmonary Carcinosarcoma, Spindle
Cell Carcinoma, and Pulmonary Blastoma: Implications for Histogeneis